Literature DB >> 30210926

MicroRNA-506 suppresses invasiveness and metastasis of human hepatocellular carcinoma cells by targeting IL8.

Zhuo Wang1, Mahui Si1, Ning Yang1, Haibin Zhang1, Yong Fu1, Kai Yan1, Yi Zong1, Nan Zhu1, Yongpeng Wei1.   

Abstract

MicroRNAs (miRNAs) have been reported to be involved in tumor metastasis. In this study, we investigated the function of miR-506 in the metastasis of human hepatocellular carcinoma (HCC). We found that miR-506 is significantly downregulated in the primary tissue of metastatic HCC and in highly metastatic HCC cell lines. Overexpression of miR-506 suppressed HCC cell migration, invasion, and metastasis both in vitro and in vivo. Furthermore, miR-506 was found to specifically target the 3' untranslated region (3'-UTR) of interleukin 8 (IL8) mRNA. Spearman's correlation analysis revealed that miR-506 expression inversely correlated with IL8 mRNA and protein expression in HCC tissue samples. IL8 treatment reversed miR-506-induced suppression of HCC cell migration and invasiveness. Thus, miR-506 acts as a tumor suppressor that may inhibit the migration, invasiveness, and metastasis of HCC cells by targeting IL8.

Entities:  

Keywords:  IL8; hepatocellular carcinoma; invasion; metastasis; miR-506

Year:  2018        PMID: 30210926      PMCID: PMC6129486     

Source DB:  PubMed          Journal:  Am J Cancer Res        ISSN: 2156-6976            Impact factor:   6.166


  25 in total

1.  Cancer statistics, 2018.

Authors:  Rebecca L Siegel; Kimberly D Miller; Ahmedin Jemal
Journal:  CA Cancer J Clin       Date:  2018-01-04       Impact factor: 508.702

2.  miR-506 acts as a tumor suppressor by directly targeting the hedgehog pathway transcription factor Gli3 in human cervical cancer.

Authors:  S-Y Wen; Y Lin; Y-Q Yu; S-J Cao; R Zhang; X-M Yang; J Li; Y-L Zhang; Y-H Wang; M-Z Ma; W-W Sun; X-L Lou; J-H Wang; Y-C Teng; Z-G Zhang
Journal:  Oncogene       Date:  2014-03-10       Impact factor: 9.867

3.  Integrated analyses identify a master microRNA regulatory network for the mesenchymal subtype in serous ovarian cancer.

Authors:  Da Yang; Yan Sun; Limei Hu; Hong Zheng; Ping Ji; Chad V Pecot; Yanrui Zhao; Sheila Reynolds; Hanyin Cheng; Rajesha Rupaimoole; David Cogdell; Matti Nykter; Russell Broaddus; Cristian Rodriguez-Aguayo; Gabriel Lopez-Berestein; Jinsong Liu; Ilya Shmulevich; Anil K Sood; Kexin Chen; Wei Zhang
Journal:  Cancer Cell       Date:  2013-02-11       Impact factor: 31.743

4.  C/EBPα Suppresses Lung Adenocarcinoma Cell Invasion and Migration by Inhibiting β-Catenin.

Authors:  Jinchang Lu; Chunling Du; Junxia Yao; Bo Wu; Yanhong Duan; Lei Zhou; Donghui Xu; Feng Zhou; Liang Gu; Hong Zhou; Yingxin Sun
Journal:  Cell Physiol Biochem       Date:  2017-07-26

Review 5.  Epithelial-mesenchymal transitions: twist in development and metastasis.

Authors:  Yibin Kang; Joan Massagué
Journal:  Cell       Date:  2004-08-06       Impact factor: 41.582

6.  Enhanced Homing of CXCR-4 Modified Bone Marrow-Derived Mesenchymal Stem Cells to Acute Kidney Injury Tissues by Micro-Bubble-Mediated Ultrasound Exposure.

Authors:  Gong Wang; Qian Zhang; Zhongxiong Zhuo; Shengzheng Wu; Yali Xu; Linru Zou; Ling Gan; Kaibin Tan; Hongmei Xia; Zheng Liu; Yunhua Gao
Journal:  Ultrasound Med Biol       Date:  2015-11-21       Impact factor: 2.998

7.  miR-720 inhibits tumor invasion and migration in breast cancer by targeting TWIST1.

Authors:  Lin-Zi Li; Chris Zhiyi Zhang; Li-Li Liu; Chun Yi; Shi-Xun Lu; Xuan Zhou; Zhao-Jie Zhang; Yi-Han Peng; Yuan-Zhong Yang; Jing-Ping Yun
Journal:  Carcinogenesis       Date:  2013-10-01       Impact factor: 4.944

8.  Effect of SDF-1/CXCR4 axis on the migration of transplanted bone mesenchymal stem cells mobilized by erythropoietin toward lesion sites following spinal cord injury.

Authors:  Jun Li; Weichun Guo; Min Xiong; Heng Han; Jie Chen; Dan Mao; Bing Tang; Hualong Yu; Yun Zeng
Journal:  Int J Mol Med       Date:  2015-09-14       Impact factor: 4.101

9.  MiR-661 promotes tumor invasion and metastasis by directly inhibiting RB1 in non small cell lung cancer.

Authors:  Feiye Liu; Yanjun Cai; Xiaoxiang Rong; Jinzhang Chen; Dayong Zheng; Lu Chen; Junyi Zhang; Rongcheng Luo; Peng Zhao; Jian Ruan
Journal:  Mol Cancer       Date:  2017-07-17       Impact factor: 27.401

10.  Downregulated miR-506 expression facilitates pancreatic cancer progression and chemoresistance via SPHK1/Akt/NF-κB signaling.

Authors:  J Li; H Wu; W Li; L Yin; S Guo; X Xu; Y Ouyang; Z Zhao; S Liu; Y Tian; Z Tian; J Ju; B Ni; H Wang
Journal:  Oncogene       Date:  2016-04-11       Impact factor: 9.867

View more
  7 in total

1.  MicroRNA-548b inhibits proliferation and invasion of hepatocellular carcinoma cells by directly targeting specificity protein 1.

Authors:  Haile Qiu; Gehong Zhang; Bin Song; Junmei Jia
Journal:  Exp Ther Med       Date:  2019-07-25       Impact factor: 2.751

2.  miR-1-3p suppresses proliferation of hepatocellular carcinoma through targeting SOX9.

Authors:  Hao Zhang; Zhenya Zhang; Lili Gao; Zhengdong Qiao; Minghua Yu; Bo Yu; Tao Yang
Journal:  Onco Targets Ther       Date:  2019-03-22       Impact factor: 4.147

3.  microRNA-944 inhibits the malignancy of hepatocellular carcinoma by directly targeting IGF-1R and deactivating the PI3K/Akt signaling pathway.

Authors:  Lili Lv; Xiaodong Wang; Tonghui Ma
Journal:  Cancer Manag Res       Date:  2019-03-29       Impact factor: 3.989

Review 4.  ChrXq27.3 miRNA cluster functions in cancer development.

Authors:  Kosuke Yoshida; Akira Yokoi; Yusuke Yamamoto; Hiroaki Kajiyama
Journal:  J Exp Clin Cancer Res       Date:  2021-03-25

5.  MicroRNA-506-3p targets SIRT1 and suppresses AMPK pathway activation to promote hepatic steatosis.

Authors:  Liang-Kai Hu; Jian-Qing Chen; Hao Zheng; Yuan-Ping Tao; Yuan Yang; Xuan-Fu Xu
Journal:  Exp Ther Med       Date:  2021-10-11       Impact factor: 2.447

6.  Comprehensive analysis of potential prognostic genes for the construction of a competing endogenous RNA regulatory network in hepatocellular carcinoma.

Authors:  Chaosen Yue; Yaoyao Ren; Hua Ge; Chaojie Liang; Yingchen Xu; Guangming Li; Jixiang Wu
Journal:  Onco Targets Ther       Date:  2019-01-14       Impact factor: 4.147

7.  Identification of a six-lncRNA signature based on a competing endogenous RNA network for predicting the risk of tumour recurrence in bladder cancer patients.

Authors:  Danfeng Zhao; Qiang Peng; Lu Wang; Cong Li; Yulin Lv; Yong Liu; Zhichao Wang; Ruizhe Fang; Jiaqi Wang; Zhongqing Liu; Wanhai Xu
Journal:  J Cancer       Date:  2020-01-01       Impact factor: 4.207

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.